Inovio Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Plymouth Meeting, PA
INO chart
What traders are saying about $INO
Latest postsInovio Pharmaceuticals, Inc. news
- Inovio faces October 30 FDA decision for Inovio Pharmaceuticals stock
ad-hoc-news.de ·
- Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
MarketWatch ·
- Inovio stock: Piper Sandler keeps USD 4.00 target for Inovio stock
ad-hoc-news.de ·
- Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors
MarketWatch ·
- Inovio Pharmaceuticals (INO) Awarded $80.4M in Legal Case Amid F
GuruFocus ·
- Inovio Says it Secured Favorable Judgment in VGXI, GeneOne Litigation
Yahoo Finance ·
- A court awards INOVIO $80.4 million, but it may not collect all of it.
Stock Titan ·
- FDA Backs PFE's Tukysa Combo in Front-Line Maintenance Breast Cancer
Yahoo Finance ·
- PGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know
Yahoo Finance ·
- PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential?
Yahoo Finance ·
- Can PGEN's AdenoVerse Pipeline Create Growth Beyond Papzimeos?
Yahoo Finance ·
- Precigen Gains 43% in 3 Months: Is It an Indication to Buy the Stock?
Yahoo Finance ·
Inovio Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $65,343 | $217,756 | $832,010 | $10.3M |
| Net income | -$85.0M | -$107.0M | -$135.0M | -$279.8M |
| Diluted EPS | $-1.81 | $-3.95 | $-6.09 | $-14.07 |
| Total assets (year end) | $74.3M | $113.2M | $171.0M | $348.5M |
| Cash and equivalents (year end) | $44.3M | $65.8M | $14.3M | $46.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Inovio Pharmaceuticals, Inc.
- Ticker
- INO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Plymouth Meeting, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1055726
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
Frequently asked questions
What exchange is Inovio Pharmaceuticals, Inc. listed on?
Inovio Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol INO.
What industry is Inovio Pharmaceuticals, Inc. in?
Inovio Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Inovio Pharmaceuticals, Inc. headquartered?
Inovio Pharmaceuticals, Inc.'s business address on file with the SEC is in Plymouth Meeting, PA.
When does Inovio Pharmaceuticals, Inc.'s fiscal year end?
Inovio Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Inovio Pharmaceuticals, Inc. report?
Inovio Pharmaceuticals, Inc. reported $65,343 in revenue for calendar year 2025, according to its SEC filings.